Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Vestex

Explore full profile

Develops, manufacturers and markets textile products and technologies

Orlando, United StatesFounded 2009Health Tech & Medtech
Valuation $50–100M Last recorded · 2017
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Vestex and the history behind them.

About Vestex

Vestex is a materials science company focused on developing and marketing advanced, active barrier protective fabrics. The company was founded in 2009 by Ben Favret III, who was inspired to create protective solutions for frontline healthcare workers regularly exposed to pathogens and fluids. Drawing from an extensive background in the healthcare industry, including roles at Pfizer and biotech startups, Favret led a team to develop the company's core technology.

The company's primary product is VESTEX®, a patented textile technology that incorporates a dual-action mechanism for protection. The outer surface of the fabric is fluid-repellent, designed to resist splatters and spills from substances like blood, urine, and sputum. This repellency acts as the first line of defense, minimizing the number of microorganisms that remain on the apparel. The fabric is then embedded with an EPA-registered antimicrobial agent that has been shown in laboratory and clinical settings to reduce Methicillin-resistant Staphylococcus aureus (MRSA) by over 99.9% on the fabric's surface. A significant milestone was achieved in May 2018, when VESTEX apparel received FDA 510(k) clearance as a Class II medical device, creating a new category for active barrier garments. This clearance was based on extensive testing that demonstrated its effectiveness in reducing MRSA accumulation on healthcare workers' clothing compared to conventional scrubs.

Vestex operates on a B2B and B2C model, primarily generating revenue through licensing agreements with manufacturers and selling its own branded apparel. The business model allows other companies to incorporate VESTEX® technology into their product lines, providing them access to the associated patents and regulatory clearances. The primary target market is the healthcare sector, supplying scrubs, lab coats, and other garments to hospitals and healthcare workers. However, the company is expanding into other markets where workers face exposure risks, including first responders, food service, and military personnel. The technology is also being positioned for consumer products like athletic wear, children's clothing, and home goods, appealing to a growing demand for safety and protection.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2009
Headquarters
Orlando, United States
Employees
17
Open positions
None listed
Dealroom signal
27.0/100
Industry
Health, Fashion
Sub-industry
Apparel, Medical Devices
Sector
Health Tech & Medtech, Tech for Medical Professionals, Hard Tech
Business model
Manufacturing, Marketplace & ecommerce
Client focus
b2b, b2c

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Oct 2017 $9.5M $38M Greenline Ventures · ADVENT LIFE SCIENCES LLP · Mercy Health · HealthQuest Capital —
EARLY VC✓Equity / VC Apr 2017 $10M $40M Undisclosed —
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Vestex website traffic

Latest recorded traffic for Vestex is 1.3K monthly website visits, up 319.4% over the last three months. Vestex's team grew 0% over the past year.

Latest monthly visits1.3K 3-month web change+319.4% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A9 investors entered at this stage

  • Advent Life Sciences
  • V-Ten Capital
  • ADVENT LIFE SCIENCES LLP
  • Alliance Healthcare Investment Fund
  • Sofinnova Investments
  • HealthQuest Capital
  • Greenline Ventures
  • Mercy Health
  • Northwell Health
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Vestex on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Vestex’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.